After 50 Years, DEA Reschedules Marijuana: A Milestone In Federal Cannabis Policy

Photo by Ben Stevens

After 50 Years, DEA Reschedules Marijuana: A Milestone In Federal Cannabis Policy

After half a century, this marks a historic milestone.

The Drug Enforcement Administration (DEA) has long held cannabis in its tight grip, designating it as a Schedule I substance alongside heroin and LSD since 1970.

But as of late, the winds of change are sweeping through the halls of federal drug policy.

In a historic move, the DEA has proposed shifting marijuana from its current Schedule I status to Schedule III under the Controlled Substances Act (CSA). This seismic shift, confirmed by the Justice Department on Tuesday, marks a significant departure from decades of staunch prohibition.

While a reclassification falls short of federal legalization, it paves the way for pivotal changes.

Under Schedule III, cannabis retains its status as illegal, albeit with nuanced implications:

  • Cannabis would still be illegal but recognized for medical use, potentially allowing prescriptions by physicians.

  • Cannabis businesses could claim federal tax deductions, currently prohibited under IRS code 280E.

  • There would be greater research opportunities, fostering more extensive exploration and leniency.

  • It could prompt states to legalize cannabis, both medicinally and recreationally.

  • Federal enforcement policies might shift in favor of state-legal cannabis operations.

  • A reevaluation of cannabis’s abuse potential relative to other substances might occur.

This rescheduling reflects a growing acknowledgment of cannabis’s therapeutic potential and might spur further state-level legalization initiatives. Already, 24 states have legalized recreational cannabis, and an additional seven have decriminalized its use as of November 2023.

Extensive scientific research, including a year-long review by the U.S. Department of Health and Human Services (HHS), supports the potential reclassification.

This review involved surveying over 30,000 healthcare professionals across 43 U.S. jurisdictions, resulting in the recommendation for medical cannabis use in over 6 million patients with 15 different medical conditions.

As the rescheduling proposal awaits review by the White House Office of Management and Budget, the head of the Food and Drug Administration (FDA) emphasizes the need for a swift decision, as there’s “no reason” for the delay.

Herb Recommended Products:

Featured Brands:

Herb Recommended Products:

READ MORE

Allswell Believes Cannabis Should Be An Affordable Right, Not A Luxury
Culture |
22.09.2022
Allswell Believes Cannabis Should Be An Affordable Right, Not A Luxury
Should I Get High Before Taking A Test?
Learn |
12.08.2019
Should I Get High Before Taking A Test?
Where Does Marijuana Grow Naturally?
Learn |
05.03.2022
Where Does Marijuana Grow Naturally?
Is It True That Mango Increases The High Of Cannabis?
Learn |
10.03.2023
Is It True That Mango Increases The High Of Cannabis?
Looking For An Affordable Medical Marijuana Card In NYC? The Answer Is FadeMD
Learn |
24.07.2023
Looking For An Affordable Medical Marijuana Card In NYC? The Answer Is FadeMD
High Culture: 10 Of The Best Cannabis Moments On The Simpsons
Culture |
12.12.2022
High Culture: 10 Of The Best Cannabis Moments On The Simpsons
Incredibles Cannabis: Edibles With Delicious Flavors
Culture |
23.02.2023
Incredibles Cannabis: Edibles With Delicious Flavors
Top 98 Funny Weed Memes
Culture |
14.08.2019
Top 98 Funny Weed Memes
10 Best THC Edibles For Anxiety: Does It Help?
Guides |
13.03.2024
10 Best THC Edibles For Anxiety: Does It Help?
How To Make Canna Oil For Savory Edibles
Learn |
26.02.2024
How To Make Canna Oil For Savory Edibles